BioCentury | Jan 31, 2018
Distillery Therapeutics

Cancer

...IRF3 expression. Next steps could include identifying and testing IRF3 inhibitors in gastric cancer models. Uluru Inc....
...International plc, Esteve S.A., GlaxoSmithKline plc and Mylan N.V. market Aptheal amlexanox for aphthous ulcers. Uluru...
BioCentury | Apr 4, 2016
Financial News

Uluru completes private placement of common stock and warrants

Uluru Inc. (OTCQB:ULUR), Addison, Texas Business: Drug delivery, Dental, Dermatology Date completed: 2016-03-29 Type: Private placement of common stock and warrants Raised: $1.8 million Shares: 25.2 million Price: $0.07 Shares after offering: 62.3 million Investors:...
BioCentury | Sep 21, 2015
Financial News

Uluru completes private placement

Uluru Inc. (OTCQB:ULUR), Addison, Texas Business: Drug delivery, Dental, Dermatology Date completed: 2015-09-11 Type: Private placement Raised: $1.6 million Shares: 4.1 million Price: $0.38 Shares after offering: 28.9 million WIR Staff Dental Dermatology...
BioCentury | Jan 6, 2014
Company News

Melmed Holdings, Uluru sales and marketing update

...On Dec. 18, 2013, Uluru and Altrazeal AG (formerly Altrazeal Trading Ltd.) added rights in India...
...is owned by a group that includes Melmed and Uluru, which has a 25% stake. Uluru...
...and parts of Europe. Uluru said the product will be launched in India in 1H14. Uluru...
BioCentury | Sep 23, 2013
Company News

Melmed Holdings, Uluru sales and marketing update

...Uluru will receive an upfront payment and is eligible for royalties under the expanded deal. Uluru...
...for wound management, and Altrazeal markets it in Austria. Melmed Holdings AG , Zug, Switzerland Uluru Inc....
BioCentury | Jan 7, 2013
Financial News

Uluru completes private placement of common stock and warrants

Uluru Inc. (OTCQB:ULUR), Addison, Texas Business: Drug delivery, Dental, Dermatology Date completed: 12/27/12 Type: Private placement of common stock and warrants Raised: $400,000 Shares: 1 million Price: $0.40 Shares after offering: 10.7 million Investor: IPMD...
BioCentury | Oct 1, 2012
Company News

Melmed Holdings, Uluru deal

...rights to commercialize Uluru's OraDisc transmucosal erodible film delivery technology for oral and dental applications. Uluru...
...Uluru for $2 million, or $0.40 per share. The price is a 100% premium to Uluru's...
...one-year warrant to purchase 3 million Uluru shares for $18 million, or $0.60 per share. Uluru...
BioCentury | Oct 1, 2012
Company News

Melmed Holdings, Uluru sales and marketing update

...Uluru said Melmed's Altrazeal Trading Ltd. subsidiary will launch Altrazeal in Austria this month. Uluru expects...
...to commercialize Altrazeal in the EU, Australia, New Zealand, North Africa and the Middle East. Uluru...
...the U.S. for wound management (see BioCentury, Jan. 23). Melmed Holdings AG , Zug, Switzerland Uluru Inc....
BioCentury | Jul 9, 2012
Financial News

Uluru completes private placement of convertible notes and warrants

...convertible notes and warrants Raised: $710,000 Shares outstanding prior: 8.1 million Investor: Inter-Mountain Capital Note: Uluru...
...The investor also received five-year warrants to purchase up to 3.1 million shares at $0.35. Uluru...
BioCentury | Mar 19, 2012
Financial News

Uluru financial update

...regain compliance with requirements for continued listing and plans to list on the OTC Markets. Uluru Inc....
Items per page:
1 - 10 of 48
BioCentury | Jan 31, 2018
Distillery Therapeutics

Cancer

...IRF3 expression. Next steps could include identifying and testing IRF3 inhibitors in gastric cancer models. Uluru Inc....
...International plc, Esteve S.A., GlaxoSmithKline plc and Mylan N.V. market Aptheal amlexanox for aphthous ulcers. Uluru...
BioCentury | Apr 4, 2016
Financial News

Uluru completes private placement of common stock and warrants

Uluru Inc. (OTCQB:ULUR), Addison, Texas Business: Drug delivery, Dental, Dermatology Date completed: 2016-03-29 Type: Private placement of common stock and warrants Raised: $1.8 million Shares: 25.2 million Price: $0.07 Shares after offering: 62.3 million Investors:...
BioCentury | Sep 21, 2015
Financial News

Uluru completes private placement

Uluru Inc. (OTCQB:ULUR), Addison, Texas Business: Drug delivery, Dental, Dermatology Date completed: 2015-09-11 Type: Private placement Raised: $1.6 million Shares: 4.1 million Price: $0.38 Shares after offering: 28.9 million WIR Staff Dental Dermatology...
BioCentury | Jan 6, 2014
Company News

Melmed Holdings, Uluru sales and marketing update

...On Dec. 18, 2013, Uluru and Altrazeal AG (formerly Altrazeal Trading Ltd.) added rights in India...
...is owned by a group that includes Melmed and Uluru, which has a 25% stake. Uluru...
...and parts of Europe. Uluru said the product will be launched in India in 1H14. Uluru...
BioCentury | Sep 23, 2013
Company News

Melmed Holdings, Uluru sales and marketing update

...Uluru will receive an upfront payment and is eligible for royalties under the expanded deal. Uluru...
...for wound management, and Altrazeal markets it in Austria. Melmed Holdings AG , Zug, Switzerland Uluru Inc....
BioCentury | Jan 7, 2013
Financial News

Uluru completes private placement of common stock and warrants

Uluru Inc. (OTCQB:ULUR), Addison, Texas Business: Drug delivery, Dental, Dermatology Date completed: 12/27/12 Type: Private placement of common stock and warrants Raised: $400,000 Shares: 1 million Price: $0.40 Shares after offering: 10.7 million Investor: IPMD...
BioCentury | Oct 1, 2012
Company News

Melmed Holdings, Uluru deal

...rights to commercialize Uluru's OraDisc transmucosal erodible film delivery technology for oral and dental applications. Uluru...
...Uluru for $2 million, or $0.40 per share. The price is a 100% premium to Uluru's...
...one-year warrant to purchase 3 million Uluru shares for $18 million, or $0.60 per share. Uluru...
BioCentury | Oct 1, 2012
Company News

Melmed Holdings, Uluru sales and marketing update

...Uluru said Melmed's Altrazeal Trading Ltd. subsidiary will launch Altrazeal in Austria this month. Uluru expects...
...to commercialize Altrazeal in the EU, Australia, New Zealand, North Africa and the Middle East. Uluru...
...the U.S. for wound management (see BioCentury, Jan. 23). Melmed Holdings AG , Zug, Switzerland Uluru Inc....
BioCentury | Jul 9, 2012
Financial News

Uluru completes private placement of convertible notes and warrants

...convertible notes and warrants Raised: $710,000 Shares outstanding prior: 8.1 million Investor: Inter-Mountain Capital Note: Uluru...
...The investor also received five-year warrants to purchase up to 3.1 million shares at $0.35. Uluru...
BioCentury | Mar 19, 2012
Financial News

Uluru financial update

...regain compliance with requirements for continued listing and plans to list on the OTC Markets. Uluru Inc....
Items per page:
1 - 10 of 48